Literaturliste

1. Abramowicz JS, Warsof SL, et al; Congenital cystic Hygroma of the neck diagnosed prenatally: outcome with normal and abnormal karyotype; Prenat Diag 9 (1989) 321-327, zitiert nach Twinnings P, McHugo JM, Pilling DW: Textbook of fetal abnormalities, 2000

2. Alan R, Ezekowitz B, et al; Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326 ( 1992) 1456-1463

3. Alqahtani A, Nguyen LT et al; 25 years’ experience with Lymphangiomas in children, Journal of Pediatric Surgery Vol. 34 (1999) 1164-1168

4. Anderson NG, Kennedy JC; Prognosis in fetal cystic hygroma, Aust NZ J Obstet Gynaecol 32 (1992) 36-39

5. Ashcroft, Holder; Pedeatric Surgery, WB Saunders (1993)

6. Azar GB, Snijders RJM, Gooden C et al; Fetal nuchal cystic Hygomata: Associated malformations and chromosomal defects, Fetal Diagn Ther 6 (1991) 46-57

7. Baccichetti C, Lenzini E et al; Spontaneous resolution of cystic hygroma in a 46, XX normal femal, Prenat Diagn 10 (1990) 399-403

8. Baraitser M, Winter RM; Fehlbildungssyndrome, Verlag Hans Huber, Bern 2001

9. Barlow C, Priebe CJ et al; Neurotoxicity in the treatment of hemangiomas with interferon alpha 2a, Proceeding from the 11th International workshop on vascular anomalies, Rome, Edizioni Luigi Pozzi 5 (1996 )

10. Belov S a;Epidemology and the social Significance of Congenital Vascular Defects aus Belov S, Loose DA, Weber J; Vascular Malformations, Periodica Angiologica 16, Einhorn-Presse-Verlag GmbH, Reinbeck (1989) 32-35

11. Belov S b; Classification, Terminology and Nosology of Congenital Vascular Defects aus Belov S, Loose DA, Weber J: Vascular Malformations; Periodica Angiologica 16, Einhorn-Presse-Verlag GmbH, Reinbeck (1989) 25-28

12. Belov S c, Loose DA, Weber J; Editors’ comment: Classification, aus: Vascular Malformations; Periodica Angiologica 16, Einhorn-Presse-Verlag GmbH, Reinbeck (1989) 29-30

13. Belov S d; Chirurgische Behandlung der kongenitalen Angiodysplasien. Zentralblatt Chirurgie 92 (1967) 1595

14. Berlien HP, Philipp C et al; Laseranwendungen in der Gefäßchirurgie, Zentralblatt für Chirurgie 118 (1993) 383-389

15. Bernard P, Chabaud JJ et al; Hygroma colli cysticum : prenatal diagnoses, prognosis, management about 42 cases, J Gynecol Obstet Biol Reprod 20 (1991) 487-495

16. Bernstein HS, Filly RA et al; Prognosis of fetus with cystic hygroma, Prenat Diagn 11 (1991) 394-355

17. Bill AH, Sumner DS;A unified concept of lymphangioma and cystic hygroma. Surg Gynecol Obstet 120 (1965) 79-86

18. Bollmann R, Sohn C et al; The second and third trimester :head and neck, In: Sohn C, Holzgreve W, eds. Ultrasound in Obstetrics and Gynecology. Stuttgart: Georg Thieme Verlag (1995) 117-172

19. Brady AF, Pandya PP et al; Outcome of chromosomally normal livebirths with increased fetal nuchal transluencency at 10-14 weeks of gestation, Ultrasound Obstet Gynecol 11 (1998) 391-400

20. Brock ME, Smith RJH, Rarey SE et al;Lymphangioma. An otolaryngologic perspective. Int J Pediatr Otorhinolaryngol 14 (1987) 133-40

21. Bronshtein M, Blumenfeld Z; Transvaginal sonography – detection of findings suggestive of fetal chromosomal anomalies in the first and early second trimesters, Prenat Diagn 12 (1992) 587-93

22. Brumfield CA, Wenstrom KD et al; Second-Trimester Cystic Hygroma: Prognosis of Septated and Nonseptated Lesions, Obstetrics & Gynecology Vol. 88 No.6 (1996) 979-982

23. Buss H, Remmle W (Hrsg); Blut und Lymphgefäße, Pathologie Band 1(1984) 269, Springer Verlag Berlin, Heidelberg, New York

24. Chait D, Yonkers AJ, Beddoe GM et al;Management of cystic hygromas. Surg Gynecol Obstet 139 (1974) 55-58

25. Chervenak FA, Isaacson G et al; Fetal cystic hygroma: Cause and natural history, N Engl J Med 309 (1983) 822-825

26. Chodirker BN, Harmon CR et al; Spontaneous resolution of a cystic hygoma in a fetus with Turners Syndrome; Renat Diagn 8 (1988) 291-296, zitiert nach Twinnings P, McHugo JM, Pilling DW; Textbook of fetal abnormalities, 2000

27. Christian SM, Koen D et al; Parental decisions following prenatal diagnosis of sex chromosome aneuploidy: a trend over time, Prenat Diagn 20 (2000) 37-40

28. Cremer HJ; Hämangiome im Kindesalter, Kongressbd-Dtsch-Ges-Chir-Kongr. 118(1998)501-506

29. Cullen MT, Gabrielli S et al; Diagnosis and significance of cystic hygroma in the first trimester, Prenat Diagn 19 (1990) 643-651

30. Dallapiccola B, Chessa L, Vignetti P et al; Increased HK 1 activity levels in the red cells of a patient with a de novo trisomy 10; Hum Gent 50 (1979) 45-49, zitiert nach Leiber B, Olbrich G; Die klinischen Syndrome, Urban und Schwarzenberg 1990

31. Descamps Ph, Jourdain Ch et al; Etiology, prognosis and management of nuchal cystic hygroma: 25 new cases and literature review, Eur J of Obstet & Gynecol and Reproductive Biology 71 (1997) 3-10

32. De Serres LM, Sie KC, Richardson MA; Lymphatic malformations of the head and neck. A proposal staging. Arch Otolaryngol Head Neck Surg 121 (1995) 577-82

33. Di Lorenzo M, Yazbeck S; Lymphangiomas, Chapter7, in Pediatric Surgery, WB Saunders 1998

34. Down JLH;Marriages of consanguinity in relation to degeneration of race, London Hosp Clinical Lectures and Reports 3 (1866) 224-236, zitiert nach Leiber B, Olbrich G; Die klinischen Syndrome, Urban und Schwarzenberg 1990

35. Drepper H;Klinik und Therapie der Lymphangiome, Hämangiome und Nävi im Kopf und Halsbereich. HNO 33 (1985) 293-302

36. Drugan A, Greb A et al; Determinants of parental decisions to abort for chromosome abnormalitiers, Prenat Diagn 10 (1990) 483-490

37. Edwards MJ, Graham JM Jr.; Posterior nuchal cystic hygroma, Clin Perinatol 17 (1990) 611-640

38. Emery PJ, Bailey CM, Ecans JN; Cystic hygroma of the head and neck. A review of 37 cases. J Laryngol Otol 98 (1984) 613-19

39. Evans MI, Sobiecki MA et al; Parental decisions to terminate/continue following abnormal cytogenetic prenatal diagnosis:” What” is still more important than “When”, Am J Med Genet 61 (1996) 353-355

40. Eyrich GK, Bruder E, Hilfiker P, et al;Temperature mapping or magnetic resonance- guided laser interstitial thermal therapy (LITT) in lymphangiomas of the head and neck. Lasers Surg Med 26 (2000) 467-76

41. Fageeh N, Manoukian J, Tewfik T et al; Management of head and neck lymphatic malformations in children. J Otolaryngol 26 (1997) 253-258

42. Finn MC, Glowacki J, Mulliken JB; Congenital Vascular Lesions: Clinical Application of a New Classification, Journal of Pediatric Surgery 18 (1983) 893-900

43. Földi M; Sekundäre Lymphödeme. In Klinische Angiologie, Rieger H, Schoop W (Hrsg.) (1998) Kapitel 48

44. Ford CE, Jones KW, Polani PE et al; A sex-chromosome anomaly in a case of gonodal dysgenesis (Turner-syndrome),Lancet I (1959)711-713, zitiert nach Leiber B, Olbrich G, Die klinischen Syndrome, Urban und Schwarzenberg 1990

45. Fujita Y, Satoh S et al; In utero Evaluation and the Long-Term Prognosis of Living Infants with Cystic Hygroma, Fetal Diagn Ther 16 (2001) 402-406

46. Gans O, Steigleder GK; Histologie der Hautkrankheiten, Springer -Verlag, Berlin (1957)

47. Giguère CM; New treatment options for lymphangioma in infants and children. Ann Otol Rhinol Laryngol 111 ( 2002) 1066-1075

48. Gohrbandt E, Gabka J, Berndorfer A; Handbuch der Plastischen Chirurgie, Bd. II, 1.Teil (1973) 73-79, Walter de Gryter

49. Greinwald JH Jr, Burke DK, Sato Y, et al; Treatment of lymphangiomas in children - an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 121 (1999) 381-387

50. Gross RE; The Surgery of Infancy and Childhood. Philadelphia : WB Saunders, 1953

51. Hafner E, Schuchter K et al; Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4.233 unselected pregnant women, Prenat Diagn 18 (1998) 29-34

52. Hancock BJ, St-Vil D, Luks FI et al;Complications of lymphangiomas in children. J Pediatr Surg 27 (1992) 220-226

53. Harashima T, Hossain M et al; Treatment of lymphangioma with Nd:YAG laser irradiation: a case report, J Clin Laser Med Surg Vol.19 No. 4 (2001) 189-191

54. Holms-Siedle M, Ryynanen M; Parental decisions regarding termination of pregnancy following prenatal detection of sex chromosome abnormality, Prenat Diagn 4 (1987) 239-244

55. Huntigton GS a, Mc Clure CFW; The development of the main lymph channels of the cat in their relation to the venous system, Anat..Rec.1 (1906-1908) 36, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

56. Huntigton GS b, Mc Clure CFW;The development of the jugular lymph sacs in the domestic cat ( Felis domestica), Am. J. Anat. 10 (1910) 177, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

57. Jacobs AH, Walton RG; The Incidence of Birthmarks in the Neonate, Pediatrics 58 (1976) 218-222

58. Johnson MP, Johnson A et al; First trimester simple hygroma: cause and outcome, Am J Obstet Gynecol 168 (1993) 156-161

59. Joppich I, Schiele U; Die Indikation zur operativen Behandlung von Hämangiomen im Säuglingsalter, Der Kinderarzt 19 (1988) 619-625

60. Kelly D, Myer CM III.;Congenital anomalies of the neck. In: Tewfik T, Kaloustian VD, eds. Congenital anomalies of the ear, nose and throat. Montreal, Canaday: Oxford University Press (1997) 344-346

61. Kennedy TL a;Cystic hygroma and lymphangioma: A rare and still unclear entity. Laryngoscope 99 (1989) 1-10

62. Kennedy TL b, Whitaker M, Pellitteri P et al; Cystic Hygroma/ Lymphangioma: A rational approach to management. Laryngoscope Vol. 111 (11) 2001 1929-1937

63. Landthaler M, Hohenleutner U, Abd El-Raheem T; Therapie vaskulärer Fehlbildungen, medwelt 46 (1995) 357-359

64. Langmann J; Medizinische Embryologie (1998), Thieme-Verlag

65. Leiber B, Olbrich G; Die klinischen Syndrome (1990), Urban und Schwarzenberg

66. Lejeune J, Gautier M, Turpin R; Etude des chromosomes somatiques de 9 enfants mongoliens, CR Acsd Sci Paris 248 (1959) 1721-1722, zitiert nach Leiber B, Olbrich G, Die klinischen Syndrome (1990) Urban und Schwarzenberg

67. Leu HJ; Pathomorphology of vascular malformations ( Analysis of 310 cases), Inter Angio 9:147-154

68. Lewis FJ;The development of the lymphatic system in rabbits, Am. J. Anat. 5 (1905) 95, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

69. Luzatto C, Midrio P, Tchaprassian Z et al; Sclerosing treatment of lymphangioma with OK-432 .Arch Dis Child 82 (2000) 361-368

70. Macken MB, Grantmyre EB; Regression of nuchal cystic hygroma in utero, J Ultrasound Med 8 (1989) 101-103

71. Mangione R, Guyon F et al; Pregnancy Outcome and Prognosis in Fetuses with Increased First-Trimester Nuchal Translucency, Fetal Diagn Ther 16 (2001) 360-363

72. Mikhail M, Kennedy R, Cramer B et al; Sclerosing of recurrent lymphangioma using OK-432. J Pediatr Surg 30 (1995) 1159-1160

73. Morgagni GB; Epistola anatomica medica XLVII, Art.20, 1768; zitiert nach Leiber B, Olbrich G, Die klinischen Syndrome (1990), Urban und Schwarzenberg

74. Mulliken JB a, Young AE; Vascular birthmarks (1988), WB Saunder Company

75. Mulliken JB b, Glowacki J; Hemangiomas and vascular malformations in infant and children: A classification based on endothelial characteristics, Plastic Reconstructive Surgery 69 (1982) 412-422

76. Mulliken JB c, Fishman SJ et al; Vascular Anomalies, Current Problems in Surgery Vol. 37 No.8 (2000) 517-520

77. Nadel A, Bromley B et al; Nuchal Thickening or Cystic Hygromas in First- and Early Second-Trimester Fetuses: Prognosis and Outcome, Obstetrics & Gynecol Vol. 82, No.1 (1993) 43-48

78. Negishi H, Yamada H et al; Outcome of nonimmune hydrops fetalis and a fetus with hydrothorax and/or ascites: With some trials of intrauterine treatment, J Perinat Med 25 (1997) 71-77

79. Newman DE, Cooperberg PL; Genetics of sonographically detected intrauterine fetal cystic hygromas, J Cancer Assoc Radiol 35 (1984) 77-79

80. Nicolaides KH a, Snijders RJM, Gosdon CM et al; Ultrasonographically detectable markers of fetal chromosomal abnormalities, Lancet 340 (1992) 703-707, zitiert nach Twinnings P, McHugo JM, Pilling DW; Textbook of fetal abnormalities, 2000

81. Nicolaides KH b, Brizot ML et al; Fetal nuchal transluency : Ultrasound screening for fetal trisomy in the first trimester of pregnancy, Br J Obstet Gynaecol 101 (1994) 782-869

82. Nicolaides KH c, Azar G et al; Fetal nuchal transluency ; ultrasound screening for chromosomal defects in first trimester of pregnancy, BJM 304 (1992) 867-869

83. Obrien WF, Cefalo Rc, Bair DG; Ultrasonographic diagnosis of fetal cystic hygroma, AmJ Obstet Gynecol 138 (1980) 464-466

84. Ogita S a, Tsuto T, Tokiwa K et al; Intracystic injection of OK-432 – a new sclerosing therapy for cystic hygroma in children. Br J Surg 74 (1987) 690-691

85. Ogita S b, Tsuto T, Deguchi E et al; OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 26 (1991) 263-270

86. Ogita S c, Tsuto T, Nakamura K et al; OK-432 Therapy in 64 Patients With Lymphangioma, J of Ped Surg, Vol 29 No. 6 (1994) 784-785

87. Ogita K, Suita S et l; Outcome of Fetal Cystic Hygroma and Experience of Intrauterine Treatment, Fetal Diagn Ther 16 (2001) 105-110

88. Paré A; The Works of the famous Chirurgion Ambrose Parey, Book 25, London:Tomas Cotes and R. Young, 1634, p.979; zitiert nach Mulliken JB, Young AE ; Vascular birthmaks (1988), WB Saunder Company

89. Pearce JM, Griffin D et al; Cystic hygromata in trisomy 18 and 21, Prenat Diagn 4 (1984) 371-375

90. Philipp C a, Poetke M, Berlien HP; Klinik und Klassifikation angeborener Gefäßerkrankungen, pädiat prax 46 (1993/94) 75-83

91. Philipp C b, Poetke M, Berlien HP, Mack M; Hämangiom oder vaskuläre Malformation? Differentialdiagnostische Überlegungen in der Frühtherapie. Der Kinderarzt 28 (1997) 1233-1242

92. Philipp C c, Poetke M, Berlien HP; Klinik und Technik der Laserbehandlung angeborener Gefäßerkrankungen. In: Berlien HP, Müller G ( Hrsg. ) Angewandte Lasermedizin, Angiologie, Ecomed (1992) Landsberg

93. Pijpers L, Reuss A et al; Fetal cystic hygroma: Prenatal diagnosis and management, Obstet Gynecol 72 (1988) 223-224

94. Poetke M a, Philipp C et al; Die Laserbehandlung von Hämangiomen und vaskulären Malformationen, Indikationen, Parameter und Applikationstechniken, Zentralblatt für Kinderchirurgie 5 (1996) 138-150

95. Poetke M b; Der Einfluß der Lasertherapie auf die Behandlungsstrategien bei Hämangiomen und vaskulären Malformationen, Dissertationsschrift vorgelegt an der Freien Universität zu Berlin (1999)

96. Pons JC, Diallo AA et al; Chorionic villus sampling after first trimester diagnosis of fetal cystic hygroma colli, Eur J Obstet Gynecol Reprod Biol 33 (1989) 141-146

97. Ravitch MM, Rush BF Jr.;Cystic hygroma. In: Welch KJ et al, editors. Pediatric Surgery. Chicago: Year Book Medical (1986) 533-539

98. Redenbacker E.A.H.;De ranula sub lingua special cum casa congenito. Monachii: Lindhauer (1828), zitiert nach Mulliken JB, Young AE ; Vascular birthmaks (1988), WB Saunder Company

99. Reinhardt MA, Nelson SC, et al; Treatment of childhood lymphangiomas with interferon- alpha. J Pediatr Hematol Oncol 19 (1997) 232-236

100. Reuss A, Pijpers L et al; The importance of chorionic villus sampling after first trimester diagnosis of cystic hygroma, Prenat Diagn 7 (1987)299-301

101. Rezai K, Holzgreve W et al; Pränatale Chromosomenbefunde bei sonographisch auffälligen Feten, Geburtshilfe Frauenheilkd 51 (1991) 211-216

102. Riechelmann H, Muehlfay G, Keck T, et al;Total, subtotal and partial surgical removal of cervicofacial lymphangiomas. Arch Otolaryngol Head Neck Surg 125 (1999) 643-648

103. Rieger H, Schoop (Hrsg); Klinische Angiologie (1998), Springer Verlag

104. Rizzo N, Pittalis MC et al; Prenatal Karyotyping in malformed Fetuses, Prenat Diagn 10 (1990) 17-23

105. Rottem S, Bronstheim M et al; First trimester transvagina sonographic diagnosis of fetal anomalies; Lancet 1 (1989) 444-445, zitiert nach Twinnings P, McHugo JM, Pilling DW; Textbook of fetal abnormalities,2000

106. Sabin FR a;On the origin of the lymphatic system from the veins and the development of the lyymph hearts and thoracic duct in the pig, Am. J. Anat. 1 (1902) 367, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

107. Sabin FR b;On the development of the superficial lymphatics in the skon of the pig, Am. J. Anat. 3 (1904)183, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

108. Sabin FR c;The development of the lymphatic nodes in the pig and their relation to the lymph hearts, Am. J. Anat. 3 (1905) 355, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

109. Sabin FR d, in Keibel F und Mall FP; Manual of Human Embryology; Philadelphia , JB Lippincott, Vol.II, 1910; zitiert nach Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

110. Saijo M, Munro IR, Mancer K; Lymphangioma- a long term follow-up study. Plast Reconstr Surg 56 (1975) 642-651

111. Sasaki Y, Chiba Y; Successful Intrauterine Treatment of Cystic Hygroma colli Using OK-432, Fetal Diagn Ther 18 (2003) 391-396

112. Saura R a, Horovitz J et al; Evaluation of chorion villus sampling, Lancet (1991) 338-449

113. Saura R b, Gauthier B; Operator experience and fetal loss rate in transabdominal chorion villus sampling, Prenat Diagn 14 (1994) 70-71

114. Schloss MD, Sweet RX, Blais C et al;Lymphangioma in children. J Otolaryngol 13 (1984) 95-98

115. Schmidt B, Schimpl G et al; OK-432 therapy of lymphangioma in children, Eur J Pediatr 155 (1996) 649-652

116. Schwanitz G, Zerres K et al; Rate of chromosomal aberrations in prenatally detected Hydrops fetalis and Hygroma colli, Hum Genet 84 (1989) 81-82

117. Schwarz U, in Földi M, Kubik I; Lehrbuch der Lymphologie, G Fischer, Stuttgart (1998)

118. Seitz J, Lymphgefäße, Embryologie des Menschen, Deutscher Ärzte-Verlag (1998) 165

119. Shapiro RS, Day DL et al; Treatment of benign vascular neoplasms with alpha interferon, Blood 78 (1991) Supp:76 a (293)

120. Sires BS, Goins CR et al; Systemic corticosteroid use in orbital lymphangioma; Ophthal Plast Reconstr Surg Vol.17 No.2 (2001) 85-90

121. Smellie W;Treatise on Midwifery and Practice of Midwifery ,Vol.II , Cases 89 and 90. 3rd ed. London: D. Wilson, 1754; zitiert nach Mulliken JB, Young AE (1988), Vascular birthmaks, WB Saunder Company

122. Smith RJH, Burke DK, Sato Y, et al;OK-432 therapy for lymphangiomas, Arch Otolaryngol Head Neck Surg 122 (1996) 1195-1199

123. Snijders RJM, Noble P et al; UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal transluencency thickness at 10-14 weeks of gestation, Lancet 352 (1998) 343-346

124. Sohn Ch, Gast AS; Das Hygroma colli (Nackenödem) als ultrasonographischer Parameter fetaler Chromosomenanomalien, Zentralbl Gynakol 119 (1997) 232-236

125. Szabó J, Gellén J et al; First-trimester ultrasoundscreening for fetal aneuploidies in women over 35 and under 35 years of age, Ultrasound Obstet Gynecol 5 (1995) 161-163

126. Tannirandorn Y, Nicolini U et al; Fetal cystic hygromata, insight gained from fetal blood sampling, Prenat Diagn 10 (1990) 37-40

127. Tanriverdi HA, Hendrik HJ et al; Hygroma Colli Cysticum: Prenatal Diagnosis and Prognosis, Am J of Perinatology 18 (2001) 415-20

128. Tasnadi GM;Pathogenesis of angiodysplasias, Acta Paed Acad Sci Hung 5 (1977) 301-309

129. Tercanli S, Holzgreve W; Das erste Trimenon. In: Ultraschall in Gynälologie und Geburtshilfe, Hrsg.: Sohn C, Holzgreve W, Stuttgart-New York: Thieme, 1. Aufl. (1995) 123-125

130. Toi A, Simpson GF; Ultrasonically evident for fetal nuchal skin thickening : is it specific for Down syndrome ?, Am J Obstet Gynecol 156 (1987) 151-153

131. Tran NN, Tran XN;Cystic hygroma in children: a report of 126 cases. J Pediar Surg 9 (1974) 191-195

132. Trauffer PMI, Anderson C et al; The natural history of euploid pregnancies with first trimester cystic hygromas; Am J Obstet Gynecol 170 (1994) 1279-128, zitiert nach Twinnings P, McHugo JM, Pilling DW; Textbook of fetal abnormalities, 2000

133. Twinnings P, McHugo JM, Pilling DW; Textbook of fetal abnormalities, 2000

134. Ville Y, Lalondrelle C et al; First-trimester diagnosis of nuchal anomalies: Significance and fetal outcome, Ultrasound Obstet Gynecol 2 (1992) 314-316

135. Vintizileos AM, Egan JFX; Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography, Am J Obstet Gynecol 172 (1994) 837-844

136. Voigt HJ, Bender E et al; Sonographische Erkennung von Hinweiszeichen für eine Chromosomenanomalie im I. und II. Trimenon, Geburtshilfe Frauenheilkd 54 (1994) 460-467

137. Watari H, Yamada H et al; A case of intrauterine medical treatment for cystic hygroma, Eur J Obstet Gynecol Reprod Biol 70 (1996) 201-203

138. Watson WJ, Miller RC et al; Ultrasonographic measurement of fetal nuchal skin to screen for chromosomal abnormalities, Am J Obstet Gynecol 170 (1994) 583-576

139. Wegener G;Über Lymphangiome, Arch. Klin. Chir.20 (1977) 641, zitiert nach: Mulliken JB, Young AE (1988), Vascular birthmarks; WB Saunder Company

140. Weissleder H et al;Gutartige Tumoren des Lymphgefäßsystems, Vasomed 6 (1994) 94-99

141 . Werner JA, Lippert BM et al; Ultrasound-Guided Interstitial Nd:YAG Laser Treatment of Voluminous Hemangiomas and Vascular Malformations in 92 Patients, Laryngoscope Vol.108 No.4 (1998) 463-470

142. White C a;Treatment of childhood angiomatous diseases with recombinant interferon alpha-2a, J Pediat 118 (1991) 59-66

143. White JM b, Chaudhry SI et al; Nd:YAG and CO2 laser therapy of oral mucosal lesions, J Clin Laser Med Surg Vol.16 No.6 (1998) 299-304

144. Williams HB; Hemangiomas and lymphangiomas, Adv Surg 15 (1982) 317-349

145. Wilson RD, Venir N et al; Fetal nuchal fluid-physiological or pathological?-in pregnancies less than 17 menstrual weeks, Prenat Diagn 12 (1992) 755-63

146. Wolff KD, Hölzle F et al; Indikationen zur primären operativen Therapie von Gefäßanommalien im Säuglingsalter, Mund Kiefer Gesichts Chir 6 (2002) 302-308

147. Zalen-Sprock van RM, Vugt van JMG et al; First trimester diagnosis of cystic Hygroma: course and outcome, Am J Obstet Gynecol 167 (1992) 94-98